Skip to main content

Table 2 Summary of practical aspects of guidelines

From: Contrast-induced nephropathy: pharmacology, pathophysiology and prevention

  ESUR ACR
Indications for SC measurement prior to contrast medium administration - Age >70
- History of: renal disease, renal cancer, proteinuria, diabetes mellitus, hypertension, gout, recent nephrotoxic drugs
- Known eGFR <60
- Intra-arterial contrast medium administration
- Age >60
- History of: renal disease, renal cancer, renal surgery, kidney transplant, single kidney, dialysis, hypertension requiring medical therapy, diabetes mellitus
- Use of metformin
Interval SC measurement – contrast medium administration Within 7 days No universally accepted interval
Volume expansion with NaCl 0.9 % i.v. 1-1.5 ml/kg/h ≥6 h before, ≥6 h after contrast medium administration 100 ml/h 6–12 h before, 4–12 h after CM administration
Volume expansion with NaHCO3 1.4 % 3 ml/kg/h 1 h before, 1 ml/kg/h 6 h after contrast medium administration No definite results
Emergency volume expansion Start as early as possible No guidelines
Post contrast medium administration SC measurement Determine eGFR 48–72 h post contrast medium administration in high risk patients No guidelines
Nephrotoxic drugs Cyclosporin
Cisplatin
Aminoglycosides
NSAID
No guidelines